Elevated TGF-β results in the poor prognosis, by inducing epithelial-to-mesenchymal transition (EMT) in tumor cells, recruiting immunosuppressive cells to TME and hampering CD8+ T cells function 191. The gene discussed is TGFB1; the disease is neoplasm.